3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
35
Myelodysplastic Syndromes
5
Neoplasms
2
Myeloproliferative Disorders
2
Lymphoma, T-Cell
2
Leukemia, Myelomonocytic, Chronic
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
GATA2 Deficiency
2
Anemia, Refractory, with Excess of Blasts
2
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Neoplasm Metastasis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia
1
Hematologic Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Tumor Virus Infections
×
Azacitidine
×
30 days
×
Clear all
No trials found.